Keyvantage Wealth LLC bought a new stake in The Procter & Gamble Company (NYSE:PG - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,591 shares of the company's stock, valued at approximately $434,000.
A number of other institutional investors also recently bought and sold shares of PG. Hancock Whitney Corp increased its position in shares of Procter & Gamble by 2.1% during the fourth quarter. Hancock Whitney Corp now owns 111,222 shares of the company's stock valued at $18,646,000 after acquiring an additional 2,243 shares during the last quarter. Empire Financial Management Company LLC grew its position in shares of Procter & Gamble by 8.9% in the fourth quarter. Empire Financial Management Company LLC now owns 24,424 shares of the company's stock valued at $4,095,000 after purchasing an additional 2,000 shares during the last quarter. Guardian Wealth Management Inc. raised its position in shares of Procter & Gamble by 0.7% in the fourth quarter. Guardian Wealth Management Inc. now owns 15,282 shares of the company's stock valued at $2,562,000 after buying an additional 100 shares during the last quarter. Voya Investment Management LLC boosted its holdings in shares of Procter & Gamble by 5.3% during the fourth quarter. Voya Investment Management LLC now owns 904,693 shares of the company's stock worth $151,672,000 after purchasing an additional 45,885 shares during the last quarter. Finally, Integrated Wealth Concepts LLC increased its position in Procter & Gamble by 8.3% during the fourth quarter. Integrated Wealth Concepts LLC now owns 158,391 shares of the company's stock worth $26,554,000 after purchasing an additional 12,103 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other news, CEO Gary A. Coombe sold 18,000 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, February 25th. The shares were sold at an average price of $171.66, for a total transaction of $3,089,880.00. Following the completion of the transaction, the chief executive officer now directly owns 22,051 shares of the company's stock, valued at $3,785,274.66. The trade was a 44.94 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.18% of the stock is currently owned by company insiders.
Analyst Ratings Changes
A number of equities analysts have weighed in on the stock. Raymond James decreased their price objective on shares of Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating for the company in a research report on Friday. Royal Bank of Canada upgraded shares of Procter & Gamble from a "sector perform" rating to an "outperform" rating and lifted their price objective for the stock from $164.00 to $177.00 in a research report on Friday. Morgan Stanley set a $180.00 target price on Procter & Gamble and gave the stock an "overweight" rating in a research report on Friday. Citigroup reduced their price objective on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating for the company in a research report on Friday. Finally, Barclays reiterated an "equal weight" rating on shares of Procter & Gamble in a research report on Thursday, March 27th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have given a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $180.79.
Check Out Our Latest Stock Analysis on PG
Procter & Gamble Price Performance
Shares of PG traded up $0.12 during mid-day trading on Monday, reaching $161.14. The stock had a trading volume of 4,171,178 shares, compared to its average volume of 7,113,102. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76. The Procter & Gamble Company has a 12 month low of $156.58 and a 12 month high of $180.43. The business has a fifty day moving average of $168.16 and a 200 day moving average of $168.32. The firm has a market cap of $377.84 billion, a price-to-earnings ratio of 25.69, a PEG ratio of 3.76 and a beta of 0.43.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.53 by $0.01. The business had revenue of $19.78 billion during the quarter, compared to analyst estimates of $20.42 billion. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. Procter & Gamble's quarterly revenue was down 2.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.52 earnings per share. Equities analysts predict that The Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Monday, April 21st will be given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.62%. The ex-dividend date is Monday, April 21st. This is an increase from Procter & Gamble's previous quarterly dividend of $1.01. Procter & Gamble's payout ratio is currently 66.98%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.